PDC*line Pharma Raises €17.5 Million in Series B2 Fin

New funding includes €11.8M in equity and €5.7M in grants. It completes the €20M B1 round of financing announced in January 2020 Proceeds will primarily be used to fund company's phase I/II trial

Related Keywords

Germany , Walloon Region , Waals Gewest , Belgium , Seongnam , Kyonggi Do , South Korea , Netherlands , United Kingdom , Wallonia , Tianma , Sichuan , China , Poland , France , Belgian , French , Korea , Chun Yang Hyun , Amanda Bown Juliette Schmitt , Aeropole Gosselies , Kostenloser Wertpapierhandel , Sangwoo Lee , Eric Halioua , Cognitive Fund , Alpha Chips Corp , Regional Investment Company Of Wallonia , Alpha Holdings , Alpha Holdings Inc , Korea Exchange , Noshaq Group , Investment Company , French Blood Bank , University Of Li , Hansongneotech Co , Shinhan Financial Group , Lg Chem Life Sciences , Lg Electronics , Belgian Federal Holding , Lg Energy Solution , Healthcare Venture Fund , Korea Investment Holdings , Life Sciences , Andrew Lloyd Associates , Participation Company , Korea Investment Partners , Brain Asset Management , Regional Investment Company , Smart Korea , Healthcare Venture , Korea Investment , Bird , Kun Yung Park , Fine Metal Mask , Organic Light Emitting Diode , Investment Partners , Shinhan Cognitive Start Up Fund , Shinhan Investment , Korean Internet Venture , Investissement De Wallonie , Federal Participation Company , Federal Investment , Non Small Cell Lung Cancer , Lloyd Associates , Line , Dharma , Raises , Billion , Series , Financing , Hound ,